Industry News, Press, Press Releases, Tru-D Technology, Uncategorized

Tru-D SmartUVC to Exhibit Clinically-Validated UV Disinfection Robot at AORN Expo

A leader in the UV disinfection industry, Tru-D SmartUVC will exhibit its patented “smart” technology at the Association for Perioperative Registered Nurses’ (AORN) Surgical Conference and Expo 2016 in Boston, Massachusetts April 2-4, 2017 at booth #1748. In addition to exhibiting and attending the AORN Surgical Conference, Tru-D has proudly

Read More
Posted 03.21.17
  • Share

Press, Tru-D News, Tru-D Technology, Uncategorized

Tru-D Corporate Profile in OR Today

Be sure to check out the latest issue of OR Today to read a corporate profile feature on Tru-D. Click here to read the online version.

Read More
Posted 03.09.17
  • Share

Hospital News, Industry News, Press, Tru-D Technology, Uncategorized

St. Charles Trials Tru-D To Reduce Infections

St. Charles Bend has started a 45-day trial of Tru-D SmartUVC in an effort to proactively reduce infection rates at its facility. If the pilot test goes as planned, the hospital will likely buy three of the devices, using them to clean hospital rooms throughout the day and then disinfect operating

Read More
Posted 02.09.17
  • Share

Disinfection, Industry News, Press, Tru-D Technology, Uncategorized

UV Light Can Aid Hospitals’ Fight to Wipe Out Drug-Resistant Superbugs

From Science and Technology Research News:  A new tool — a type of ultraviolet light called UVC — could aid hospitals in the ongoing battle to keep drug-resistant bacteria from lingering in patient rooms and causing new infections. Some hospitals have already begun using UVC machines in addition to standard

Read More
Posted 02.01.17
  • Share

Industry News, Press, Press Releases, Studies, Tru-D News, Tru-D Technology

Becker’s Infection Control: Enhancing terminal room cleaning with UV light can cut superbug transmission

Adding ultraviolet-C light disinfection to standard terminal room disinfection practices can reduce transmission drug-resistant organisms by a cumulative 30 percent, according to a study led by Duke Health and published in The Lancet. The trial took place from 2012 to 2014 at nine hospitals — three Duke University Health System

Read More
Posted 01.19.17
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »